Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05185310 · ClinicalTrials.gov registry record · NA
Strategies in Patients Undergoing Repeat AF Ablation
A NA study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT05185310: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT05185310 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05185310, a NA study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The aim of the proposed research project is to compare the efficacy of three different ablation strategies in patients with atrial fibrillation (AF) who are undergoing their first repeat catheter ablation for recurrent AF.
Interventions
- PROCEDURE Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-12-13 |
| Est. Completion | 2023-02-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05185310
The ClinicalTrials.gov registry entry for NCT05185310 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ablation is the first listed.
NCT05185310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05185310 about?
NCT05185310 is a clinical study titled "Strategies in Patients Undergoing Repeat AF Ablation". The aim of the proposed research project is to compare the efficacy of three different ablation strategies in patients with atrial fibrillation (AF) who are undergoing their first repeat catheter ablation for recurrent AF.
What is the current status of trial NCT05185310?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2021-12-13. Estimated completion is 2023-02-03.
What interventions are being tested in trial NCT05185310?
The interventions under investigation include: Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT05185310?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.